Shilpa Medicare Ltd banner

Shilpa Medicare Ltd
NSE:SHILPAMED

Watchlist Manager
Shilpa Medicare Ltd Logo
Shilpa Medicare Ltd
NSE:SHILPAMED
Watchlist
Price: 331.1 INR 1.32% Market Closed
Market Cap: ₹64.8B

Relative Value

The Relative Value of one SHILPAMED stock under the Base Case scenario is hidden INR. Compared to the current market price of 331.1 INR, Shilpa Medicare Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SHILPAMED Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

SHILPAMED Competitors Multiples
Shilpa Medicare Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Shilpa Medicare Ltd
NSE:SHILPAMED
64.8B INR 5 48.9 19.2 28.4
US
Eli Lilly and Co
NYSE:LLY
983.7B USD 15.1 47.7 32.1 34.2
US
Johnson & Johnson
NYSE:JNJ
585.8B USD 6.2 21.9 15.2 18.6
CH
Roche Holding AG
SIX:ROG
286.9B CHF 4.7 30.6 12.9 15
UK
AstraZeneca PLC
LSE:AZN
233.3B GBP 5.4 31.2 17.2 24.2
CH
Novartis AG
SIX:NOVN
241.3B CHF 5.5 22.2 13.7 17.6
US
Merck & Co Inc
NYSE:MRK
302B USD 4.6 16.5 10.3 12.1
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.7 11.4
US
Pfizer Inc
NYSE:PFE
156.8B USD 2.5 20.2 7.5 10
US
Bristol-Myers Squibb Co
NYSE:BMY
123.7B USD 2.6 17.5 6.8 8.8
P/E Multiple
Earnings Growth PEG
IN
Shilpa Medicare Ltd
NSE:SHILPAMED
Average P/E: 27
48.9
96%
0.5
US
Eli Lilly and Co
NYSE:LLY
47.7
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
21.9
7%
3.1
CH
Roche Holding AG
SIX:ROG
30.6
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
31.2
26%
1.2
CH
Novartis AG
SIX:NOVN
22.2
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.5
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
7%
1.9
US
Pfizer Inc
NYSE:PFE
20.2
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.5
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Shilpa Medicare Ltd
NSE:SHILPAMED
Average EV/EBITDA: 43.4
19.2
41%
0.5
US
Eli Lilly and Co
NYSE:LLY
32.1
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.2
2%
7.6
CH
Roche Holding AG
SIX:ROG
12.9
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
17.2
11%
1.6
CH
Novartis AG
SIX:NOVN
13.7
9%
1.5
US
Merck & Co Inc
NYSE:MRK
10.3
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.7
7%
1.4
US
Pfizer Inc
NYSE:PFE
7.5
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
6.8
-13%
N/A